Septerna
Launching
Septerna is unlocking the full potential of G protein-coupled receptor (GPCR) drug targets. They are creating the opportunity to develop the next generation of impactful new medicines for patients across therapeutic areas.
Their highly experienced leadership team is fulfilling that scientific promise, but they needed to bring cohesion and modernity to the brand and story for their biggest moment yet — ringing the NASDAQ opening bell and becoming a publicly traded company.
Services
A Successful IPO
We started by rendering out GPCRs, the foundation of their pioneering approach to drug discovery.
We developed core assets, from hero renderings to photography of their labs, their offices, and teams, and brought it all together in a new website that would coincide with their IPO announcement.
SEPN_Items
We updated their brand assets, streamlining the core logo and palette.
Septerna_Web
Then developed a highly-engaging website and mobile experience.
SEPN_GPCR Rendering3
We created dozens of renderings and animations of their core GPCR-based science.
Septerna_Videograb2
We shot key videos and images within their lab and offices.
Septerna_Logo_Mockup
Bringing the brand to life in their built environment.
SEPN_NASDAQ
All the work led to this pinnacle moment on the floor of NASDAQ.
From the clients
Share this: